Two new studies provide robust epidemiological evidence and a mechanistic link, with potential implications for strategies that target Epstein–Barr virus.
This is a preview of subscription content, access via your institution
Access Nature and 54 other Nature Portfolio journals
Get Nature+, our best-value online-access subscription
$29.99 per month
cancel any time
Subscribe to this journal
Receive 12 print issues and online access
$189.00 per year
only $15.75 per issue
Rent or buy this article
Get just this article for as long as you need it
Prices may be subject to local taxes which are calculated during checkout
Banwell, B. et al. Lancet Neurol. 10, 436–445 (2011).
Bar-Or, A. et al. Trends Mol. Med. 26, 296–310 (2020).
Nourbakhsh, B. et al. Ann. Neurol. 89, 1234–1239 (2021).
Goodin, D. S. Med Res Arch 9, 29 (2021).
Veroni, C. & Aloisi, F. Front. Immunol. 12, 665718 (2021).
Bjornevik, K. et al. Science 375, 296–301 (2022).
Lanz, T. V. et al. Nature 603, 321–327 (2022).
Levin, L. I., Munger, K. L., O’Reilly, E. J., Falk, K. I. & Ascherio, A. Ann. Neurol. 67, 824–830 (2010).
Soldan, S. S. & Lieberman, P. M. Drug Discov. Today Dis. Models 32, 35–52 (2020).
Cencioni, M. T., Mattoscio, M., Magliozzi, R., Bar-Or, A. & Muraro, P. A. Nat. Rev. Neurol. 17, 399–414 (2021).
Lassmann, H., Niedobitek, G., Aloisi, F. & Middeldorp, J. M. Brain 134, 2772–2786 (2011).
Messick, T. E. et al. Sci. Transl. Med. 11, 5612 (2019).
A.B.-O. has participated as a speaker in meetings sponsored by and has received consulting fees from Accure, Atara Biotherapeutics, Biogen, BMS/Celgene/Receptos, GlaxoSmithKline, Gossamer, Janssen/Actelion, Medimmune, Merck/EMD Serono, Novartis, Roche/Genentech and Sanofi-Genzyme, and has received grant support to the University of Pennsylvania from Biogen Idec, Roche/Genentech, Merck/EMD Serono and Novartis.
Rights and permissions
About this article
Cite this article
Bar-Or, A., Banwell, B., Berger, J.R. et al. Guilty by association: Epstein–Barr virus in multiple sclerosis. Nat Med 28, 904–906 (2022). https://doi.org/10.1038/s41591-022-01823-1
This article is cited by
Epstein–Barr virus and multiple sclerosis
Nature Reviews Microbiology (2023)